FAM83B mediates EGFR- and RAS-driven oncogenic transformation
Open Access
- 4 September 2012
- journal article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 122 (9), 3197-3210
- https://doi.org/10.1172/JCI60517
Abstract
Aberrant regulation of growth signaling is a hallmark of cancer development that often occurs through the constitutive activation of growth factor receptors or their downstream effectors. Using validation-based insertional mutagenesis (VBIM), we identified family with sequence similarity 83, member B (FAM83B), based on its ability to substitute for RAS in the transformation of immortalized human mammary epithelial cells (HMECs). We found that FAM83B coprecipitated with a downstream effector of RAS, CRAF. Binding of FAM83B with CRAF disrupted CRAF/14-3-3 interactions and increased CRAF membrane localization, resulting in elevated MAPK and mammalian target of rapamycin (mTOR) signaling. Ablation of FAM83B inhibited the proliferation and malignant phenotype of tumor-derived cells or RAS-transformed HMECs, implicating FAM83B as a key intermediary in EGFR/RAS/MAPK signaling. Analysis of human tumor specimens revealed that FAM83B expression was significantly elevated in cancer and was associated with specific cancer subtypes, increased tumor grade, and decreased overall survival. Cumulatively, these results suggest that FAM83B is an oncogene and potentially represents a new target for therapeutic intervention.Keywords
This publication has 27 references indexed in Scilit:
- TGF-β signaling engages an ATM-CHK2-p53–independent RAS-induced senescence and prevents malignant transformation in human mammary epithelial cellsProceedings of the National Academy of Sciences, 2011
- Impaired Binding of 14-3-3 to C-RAF in Noonan Syndrome Suggests New Approaches in Diseases with Increased Ras SignalingMolecular and Cellular Biology, 2010
- Validation-based insertional mutagenesis identifies lysine demethylase FBXL11 as a negative regulator of NFκBProceedings of the National Academy of Sciences of the United States of America, 2009
- Significance of Tyrosine Kinase Inhibitors in the Treatment of Metastatic Breast CancerBreast Care, 2009
- Epithelial Progeny of Estrogen-Exposed Breast Progenitor Cells Display a Cancer-like MethylomeCancer Research, 2008
- Biochemical Analysis of Phospholipase DMethods in enzymology, 2007
- A Genetic Screen for Candidate Tumor Suppressors Identifies RESTCell, 2005
- Limited role of N-terminal phosphoserine residues in the activation of transcription by p53Oncogene, 2004
- Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cellsGenes & Development, 2001
- Epidermal growth factor receptor expression as a prognostic indicator in breast cancerEuropean Journal of Cancer and Clinical Oncology, 1991